取回
NEXEL Earns the First ISO/IEC 17025:2017 Accreditation for iPSC-derived Cardiomyocyte-based Cardiac Safety Testing
Celogics highlights its iPSC derived Cardiomyocytes at the Society of Toxicology (SOT) Annual Meeting and Tox Expo
Celogics Licenses in NEXEL's Cardiosight-S for Global Distribution
Nexel, 'Chinese Patent Registration' for New Drug Candidate for NASH Fibrosis
Curi Bio and NEXEL Announce Celogics, Joint Venture to Develop Leading iPSC-derived Cell Products
NEXEL Co., Ltd. signed Strategic Business Partnership Agreement with Next&Bio
Korea Ministry of Food and Drug Safety Issues a Revised Guideline on Cardiac Safety Pharmacology
NEXEL Co., Ltd. raises USD 15.6 million in bridge round
NEXEL Co., Ltd. signs Memorandum of Understanding with KangWon National University School of Medicine
NEXEL, "US Patent Registration" for New Drug Candidate for Liver Fibrosis
请先输入您的密码。
密码
关闭窗口确认